ADAR1 Capital Management LLC acquired a new position in shares of Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACCU – Free Report) during the 4th quarter, Holdings Channel reports. The firm acquired 500,000 shares of the company’s stock, valued at approximately $5,065,000. Oaktree Acquisition Corp. III Life Sciences makes up 1.0% of ADAR1 Capital Management LLC’s holdings, making the stock its 24th biggest position.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Kepos Capital LP bought a new stake in Oaktree Acquisition Corp. III Life Sciences in the 4th quarter valued at about $709,000. Athos Capital Ltd acquired a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the 4th quarter worth $507,000. Finally, Rangeley Capital LLC bought a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the fourth quarter worth $101,000.
Oaktree Acquisition Corp. III Life Sciences Stock Performance
OACCU stock opened at $10.27 on Monday. The firm has a 50-day moving average price of $10.23. Oaktree Acquisition Corp. III Life Sciences has a 12 month low of $9.99 and a 12 month high of $10.60.
About Oaktree Acquisition Corp. III Life Sciences
We are a newly organized blank check company incorporated on June 28, 2024, as a Cayman Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination.
Read More
- Five stocks we like better than Oaktree Acquisition Corp. III Life Sciences
- How to Read Stock Charts for Beginners
- 3 ETFs That Offer Easy Exposure to the AI Revolution
- What is a Dividend King?
- 2 Ways to Win the Tarrif Trade: Toyota and Tesla
- High Flyers: 3 Natural Gas Stocks for March 2022
- New Tariffs May Bring Liberation to These 3 Steel Stocks
Want to see what other hedge funds are holding OACCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACCU – Free Report).
Receive News & Ratings for Oaktree Acquisition Corp. III Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oaktree Acquisition Corp. III Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.